Bye Bye Zyprexa

[Anonymous]

8 days left until the patent expiration. Q3 earnings call this Tuesday, investors take note. It's all downhill from here.

 

[Anonymous]

8 days left until the patent expiration. Q3 earnings call this Tuesday, investors take note. It's all downhill from here.

http://www.biotechblog.com/2011/10/06/drug-patent-expirations-in-october-2011/

 

[Anonymous]

Fat Fuckleiter should kill himself.

 

[Anonymous]

Drug Patent Expirations in October 2011
Tradename Applicant Generic Name Patent Number Patent Expiration

SYMBYAX Lilly fluoxetine hydrochloride; olanzapine 5,229,382*PED Oct 23, 2011
ZYPREXA RELPREVV Eli Lilly Co olanzapine pamoate 5,229,382*PED Oct 23, 2011
ZYPREXA Lilly olanzapine 5,627,178*PED Oct 23, 2011
ZYPREXA Lilly olanzapine 5,817,656*PED Oct 23, 2011
ZYPREXA Lilly olanzapine 5,817,657*PED Oct 23, 2011
ZYPREXA Lilly olanzapine 5,817,655*PED Oct 23, 2011
ZYPREXA Lilly olanzapine 5,229,382*PED Oct 23, 2011
ZYPREXA ZYDIS Lilly olanzapine 5,229,382*PED Oct 23, 2011

 

[Anonymous]

Our strategy and leadership will prevail.

 

[Anonymous]

The amazing note is the expiration of Symbyax's patent. With it's "Best in Class" efficacy and unique pharmacology there must be generic companies across the globe that are manufacturing and training their sales forces to launch this unique molecule.

 

[Anonymous]

The amazing note is the expiration of Symbyax's patent. With it's "Best in Class" efficacy and unique pharmacology there must be generic companies across the globe that are manufacturing and training their sales forces to launch this unique molecule.

"unique molecule" ??? you must be joking.

 

[Anonymous]

8 days left until the patent expiration. Q3 earnings call this Tuesday, investors take note. It's all downhill from here.

In my geography, Effient is more than making up for what we'll lose from Zyprexa.

 

[Anonymous]

In my geography, Effient is more than making up for what we'll lose from Zyprexa.

that
Is

fUNNY!

 

[Anonymous]

For the past two years, Lilly has cutting its workforce by about 5,000 jobs worldwide to get ready for the downturn in sales. But in the short-run, that is costing Lilly millions of dollars. In the third quarter of 2011, Lilly recognized a charge of$25.2 million for restructuring, primarily related to severance costs to laid-off workers
The company said earnings per share guidance excludes potential future restructuring charges

 

[Anonymous]

Zyprexa is officialy Generic